Overall, oestrogen levels and oestrogen-based replacement therapies (including gender-transition therapies) will need to be carefully considered in the light of the APOE carrier status to prevent undesired brain disorders and cognitive decline. This evidence concerns the gene APOE and Mental deterioration.